NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









CancerNavigator, Inc.

CancerNavigator, Inc.

Private
Washington D.C.Healthcare & Life Scienceshttps://www.cancernavigator.com/

Last Round

Seed Round

Feb 24, 2026

Momentum

Top 25%

of companies Caplight tracks

Company Overview

CancerNavigator, Inc. is a healthtech company that provides cancer navigation and analytics services to guide patients to expert care through employer and union health plans.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Healthcare Analytics

Business Model

B2B2C

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

oncology navigationcancer care navigationpatient advocacycare coordinationemployer health benefitsoncology nurse navigationhealthcare navigationcancer support servicesprovider matchingclinical navigationhealthcare analyticsB2B2C healthcaredigital health navigationhealth equitycare navigation platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CancerNavigator, Inc. Comps

Public and private peers based on sector, stage, and business model.

CancerNavigator, Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

CancerNavigator, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundFeb 24, 2026

Key People

Founding team and executive leadership

Lexi Slotkoff Loudon

Chief Operating Officer

Executive Team

CancerNavigator, Inc. Investors

Notable investors and investment history

CancerNavigator, Inc. investors
InvestorRounds
Heuristic Capital PartnersSeed Round
Oncology VenturesSeed Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 29, 2026

    Grew 21% QoQ, from 24 to 29 employees.

CancerNavigator, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

CancerNavigator, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about CancerNavigator, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersWashington D.C.
Employee Range29
Year Founded2019
Last FundingFeb 24, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.